[Efficiency of rituximab in acquired hemophilia: report of two cases and review of literature].
Acquired hemophilia due to an inhibitor of factor VIII is a rare clinical situation. Rituximab is now used in the treatment of acquired hemophilia. We report two cases of acquired hemophilia treated by rituximab with efficiency. Rituximab appears to be a first line immunosuppressive therapy in acquired hemophilia, especially in post-partum hemophilia.